A subscription to JoVE is required to view this content. Sign in or start your free trial.

Method Article

Whole-brain Segmentation and Change-point Analysis of Anatomical Brain MRI—Application in Premanifest Huntington's Disease

11.2K views

⸱

DOI:

10.3791/57256

⸱

June 9th, 2018

 ,  ,  ,  ,  , 

In This Article

Summary

This paper describes a statistical model for volumetric MRI data analysis, which identifies the "change-point" when brain atrophy begins in premanifest Huntington's disease. Whole-brain mapping of the change-points is achieved based on brain volumes obtained using an atlas-based segmentation pipeline of T1-weighted images.

Abstract

Recent advances in MRI offer a variety of useful markers to identify neurodegenerative diseases. In Huntington's disease (HD), regional brain atrophy begins many years prior to the motor onset (during the "premanifest" period), but the spatiotemporal pattern of regional atrophy across the brain has not been fully characterized. Here we demonstrate an online cloud-computing platform, "MRICloud", which provides atlas-based whole-brain segmentation of T1-weighted images at multiple granularity levels, and thereby, enables us to access the regional features of brain anatomy. We then describe a regression model that detects statistically significant inflection points, at which regional brain atrophy starts to be noticeable, i.e. the "change-point", with respect to a disease progression index. We used the CAG-age product (CAP) score to index the disease progression in HD patients. Change-point analysis of the volumetric measurements from the segmentation pipeline, therefore, provides important information of the order and pattern of structural atrophy across the brain. The paper illustrates the use of these techniques on T1-weighted MRI data of premanifest HD subjects from a large multicenter PREDICT-HD study. This design potentially has wide applications in a range of neurodegenerative diseases to investigate the dynamic changes of brain anatomy.

Introduction

Magnetic resonance imaging (MRI) has substantially enhanced our ability to examine the brain anatomy and functions in neurodegenerative diseases1,2,3. T1-weighted structural MRI is one of most widely adopted imaging tools in routine clinical practice to assess the brain anatomy and related pathology. Quantitative analysis of the high-resolution T1-weighted images provides useful markers to measure anatomical changes during brain degeneration. In particular, segmentation based quantification approaches effectively reduces the image dimensionality from voxel level (on the order....

Access restricted. Please log in or start a trial to view this content.

Protocol

1. Atlas-based Whole Brain Segmentation

  1. Data preparation
    1. Convert three-dimensional (3D) T1-weighted images, typically acquired with MPRAGE (magnetization-prepared rapid gradient-echo) sequence, from vendor-specific DICOM (Digital Imaging and Communication) format to Analyzed format. Note that the cloud computation requires users' data to be transferred to remote clusters. According to the Health Insurance Portability and Accountability Act (HIPPA), remove the patients' personal identification information from the image files.
      NOTE: MRICloud offers a DICOM-to-Analyze converter (https://braingps.mricloud.org/t1pre....

Access restricted. Please log in or start a trial to view this content.

Results

Using the procedures described in 1.1-1.3, whole brain segmentation maps can be obtained from MRICloud. In the current version of atlas (V9B), 283 parcels are segmented at the finest granularity (level 5), which can be grouped to different levels of granularity, e.g., from hemisphere to lobules and parcels, according to specific ontology definitions. Figure 3 shows two types of multi-level segmentations at five levels, in axial and coronal views. For.......

Access restricted. Please log in or start a trial to view this content.

Discussion

As demonstrated in this paper, whole-brain segmentation of brain MRI can be conveniently achieved using our online platform MRICloud. T1-weighted MRI based volumetric marker has shown to be robust and sensitive to a range of neurodegenerative diseases1,2,3. The volumetric measures are used for various downstream analysis, such as mathematical modeling, and feature-selection and classification analysis to assist clinical diagnosi.......

Access restricted. Please log in or start a trial to view this content.

Disclosures

The authors have nothing to disclose.

Acknowledgements

We thank the PREDICT-HD investigators, particularly, Dr. Hans Johnson and Dr. Jane S. Pauslen from University of Iowa, for their generosity in sharing the MRI data and constructive discussion on the data analysis and results.

This work is supported by NIH grants R21 NS098018, P50 NS16375, NS40068, R01 NS086888, R01 NS084957, P41 EB015909, P41 EB015909, R01 EB000975, R01 EB008171, and U01 NS082085.

....

Access restricted. Please log in or start a trial to view this content.

Materials

List of materials used in this article
NameCompanyCatalog NumberComments
MATLABMathworksN/AVersion 2015b and above
Dell WorkstationDellDell Precision T5500 (Intel Xeon CPU)

References

  1. Paulsen, J. S., et al. Clinical and Biomarker Changes in Premanifest Huntington Disease Show Trial Feasibility: A Decade of the PREDICT-HD Study. Front Aging Neurosci. 6, 78(2014).
  2. Jack, C. R. Jr, et al.

Access restricted. Please log in or start a trial to view this content.

Reprints and Permissions

Explore More Articles

T1-weighted MRIMRICloud PlatformAtlas-based SegmentationVolumetric AnalysisCAP ScoreMultiAtlas BatchMATLAB GUI